Response to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia

Simple item page
dc.contributor.authorAlex Lopez
dc.contributor.authorJose Fernando Vera‐Chamorro
dc.contributor.authorAilim Margarita Carías Domínguez
dc.contributor.authorMónica Pinilla‐Roncancio
dc.contributor.authorRocío López
dc.contributor.authorGonzalo Andrés Montaño Rozo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:50:54Z
dc.date.available2026-03-22T19:50:54Z
dc.date.issued2025
dc.description.abstractThis is the first study to assess PPI response in Colombian pediatric EoE patients, demonstrating a response rate consistent with existing literature. Histologic evaluation was identified as the most reliable marker of treatment success, underscoring the critical role of histopathological follow-up in this disease.
dc.identifier.doi10.1155/cjgh/4633813
dc.identifier.urihttps://doi.org/10.1155/cjgh/4633813
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/78479
dc.language.isoen
dc.publisherPulsus Group
dc.relation.ispartofCanadian Journal of Gastroenterology and Hepatology
dc.sourceUniversidad de Los Andes
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectEosinophilic esophagitis
dc.subjectGastroenterology
dc.subjectDermatology
dc.subjectDisease
dc.titleResponse to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia
dc.typearticle

Files

Collections

Artículo Científico Publicado